Alza Challenges Antitrust Claims In Ditropan Case
Alza Corp. has shot back at allegations raised by a purported class of indirect purchasers who claim that the Johnson & Johnson subsidiary violated federal and California antitrust laws by trying...To view the full article, register now.
Already a subscriber? Click here to view full article